-
Clinical documentation of patient-reported medical cannabis use in primary care: Toward scalable extraction using natural language processing methods.
Carrell DS, Cronkite DJ, Shea M, Oliver M, Luce C, Matson TE, Bobb JF, Hsu C, Binswanger IA, Browne KC, Saxon AJ, McCormack J, Jelstrom E, Ghitza UE, Campbell CI, Bradley KA, Lapham GT. Clinical documentation of patient-reported medical cannabis use in primary care: Toward scalable extraction using natural language processing methods. Substance Abuse 2022;43(1):917-924.
-
A likely responder approach for the analysis of randomized controlled trials.
Laska E, Siegel C, Lin Z. A likely responder approach for the analysis of randomized controlled trials. Contemporary Clinical Trials 2022;114:106688.
-
Cost of hepatitis C care facilitation for HIV/hepatitis C co-infected people who use drugs.
Gutkind S, Starbird LE, Murphy SM, Teixeira PA, Gooden LK, Matheson T, Feaster DJ, Jain MK, Masson CL, Perlman DC, del Rio C, Metsch LR, Schackman BR. Cost of hepatitis C care facilitation for HIV/hepatitis C co-infected people who use drugs. Drug and Alcohol Dependence 2022;232:109265.
-
Sex-based differences in psychiatric symptoms and opioid abstinence during buprenorphine/naloxone treatment in adolescents with opioid use disorders.
Hammond CJ, Park G, Kady A, Rathod K, Rahman N, Vidal C, Wenzel K, Fishman MJ. Sex-based differences in psychiatric symptoms and opioid abstinence during buprenorphine/naloxone treatment in adolescents with opioid use disorders. Journal of Substance Abuse Treatment 2022;133:108495.
-
Recruitment into a clinical trial of people living with uncontrolled HIV infection who inject drugs: A Site case report from the CTN 67 CHOICES study.
Tookes H, Ucha J, Rodriguez AE, Suarez E, Alonso E, Metsch LR, Feaster DJ, Bartholomew TS, Hoffman KA, Korthuis PT. Recruitment into a clinical trial of people living with uncontrolled HIV infection who inject drugs: A Site case report from the CTN 67 CHOICES study. Journal of Behavioral Health Services & Research 2022;49:240-251.
-
Disparities in digital access among American rural and urban households and implications for telemedicine-based services.
Curtis ME, Clingan SE, Guo H, Zhu Y, Mooney LJ, Hser Y. Disparities in digital access among American rural and urban households and implications for telemedicine-based services. Journal of Rural Health 2022;38(3):512-518.
-
Gender differences in the associations of multiple psychiatric and chronic conditions with major depressive disorder among patients with opioid use disorder.
Nwabueze C, Elom H, Liu S, Walter SM, Sha Z, Acevedo P. Gender differences in the associations of multiple psychiatric and chronic conditions with major depressive disorder among patients with opioid use disorder. Journal of Addictive Diseases 2022;40(2):168-178.
-
Polysubstance use, mood disorders, and chronic conditions with anxiety in opioid patients.
Liu S, Nwabueze C, Pan Y, Walter SM, Su B, Xu C, Winstanley EL, Wang K. Polysubstance use, mood disorders, and chronic conditions with anxiety in opioid patients. Western Journal of Nursing Research 2022;44(12):1088-1099.
-
Graded response item response theory in scaling suicidal thoughts and behaviors among trauma-exposed women with substance use disorders.
Fitzpatrick SS, Morgan-Lopez AA, Saraiya TC, Back SE, Killeen TK, Norman SB, Lopez-Castro T, Ruglass LM, Saavedra LM, Hien DA. Graded response item response theory in scaling suicidal thoughts and behaviors among trauma-exposed women with substance use disorders. Psychology of Addictive Behaviors 2022; 36(4):397-409.
-
Therapy dose mediates the relationship between buprenorphine/naloxone and opioid treatment outcomes in youth receiving medication for opioid use disorder treatment.
Hammond CJ, Kady A, Park G, Vidal C, Wenzel K, Fishman MJ. Therapy dose mediates the relationship between buprenorphine/naloxone and opioid treatment outcomes in youth receiving medication for opioid use disorder treatment. Journal of Addiction Medicine 2022;16(2):e97-e104.